Scandinavian Real Heart AB (Publ) (STO:HEART)
Sweden · Delayed Price · Currency is SEK 13.50
+0.30 (2.27%)
Mar 24, 2026, 4:10 PM CET
STO:HEART Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
114.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 1.93K | 1.99K | - |
| Dec 31, 2023 | -62.00 | -10.06K | - |
| Dec 31, 2022 | 10.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 489.70M |
| Arcoma AB | 130.80M |
| Integrum AB | 98.18M |
| ScandiDos AB | 56.81M |
| Promimic AB | 51.06M |
| BrainCool AB | 38.69M |
| Nosa Plugs AB | 24.12M |
| Episurf Medical AB | 20.20M |